Global Brain Hemorrhage Pipeline Review 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Brain Hemorrhage - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Brain Hemorrhage, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Brain Hemorrhage and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Brain Hemorrhage Overview
  3. Therapeutics Development
  4. Pipeline Products for Brain Hemorrhage - Overview
  5. Pipeline Products for Brain Hemorrhage - Comparative Analysis
  6. Brain Hemorrhage - Therapeutics under Development by Companies
  7. Brain Hemorrhage - Therapeutics under Investigation by Universities/Institutes
  8. Brain Hemorrhage Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Brain Hemorrhage - Products under Development by Companies
  13. Brain Hemorrhage - Products under Investigation by Universities/Institutes
  14. Brain Hemorrhage - Companies Involved in Therapeutics Development
  • Edge Therapeutics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fina Biotech
  • MediPost Co., Ltd.
  • Pfizer Inc.
  • Remedy Pharmaceuticals, Inc.

For more information visit http://www.researchandmarkets.com/research/4vj547/brain_hemorrhage

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Sector: Central Nervous System Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Sector: Central Nervous System Drugs